First New Drug for Liver Cancer in a Decade: Regorafenib

The US Food and Drug Administration (FDA) has expanded the indication for regorafenib (Stivarga, Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib (Nexavar, Bayer).
Expansion of regorafenib's indication marks the first FDA-approved treatment for a liver cancer in almost a decade!

Medscape article: http://www.medscape.com/viewarticle/879216?src=soc_fb_170427_mscpedt_news_onc_livercancer

Comments

Post a Comment

Popular posts from this blog

Bioinspired coating for medical devices repels blood and bacteria

Any device implanted in the body or in contact with flowing blood faces two critical challenges that can threaten the life of the patient the device is meant to help: blood clotting and bacterial infection. A team of Harvard scientists and engineers may have a solution. They developed a new surface coating for medical devices using materials already approved by the Food and Drug Administration (FDA). The coating repelled blood from more than 20 medically relevant substrates the team tested – made of plastic to glass and metal – and also suppressed biofilm formation in a study reported in Nature Biotechnology. The team implanted medical-grade tubing and catheters coated with the material in large blood vessels in pigs, and it prevented blood from clotting for at least eight hours without the use of blood thinners such as heparin.  The link of the article: https://wyss.harvard.edu/bioinspired-coating-for-medical-devices-repels-blood-and-bacteria/
Read more

Polycystic Ovary Syndrome Might Start in The Brain, Not The Ovaries!

A new study has found evidence that the common and debilitating reproductive condition, polycystic ovary syndrome, could start in the brain, not the ovaries, as researchers have long assumed. If verified, the research could change the way we think about the painful and severely misunderstood condition, which affects at least one in 10 women worldwide. http:// www.sciencealert.com/ polycystic-ovary-syndrome-m ight-start-in-the-brain-no t-the-ovaries
Read more

Plain packets help smokers quit by killing brand identities

The proof is in the packaging. Making all cigarette packets look the same reduces the positive feelings smokers associate with specific brands and encourages quitting, Australian research shows. The findings come ahead of the UK and Ireland introducing plain tobacco packaging in May. Australia was the first nation to introduce such legislation in December 2012. Since then, all cigarettes have been sold in plain olive packets with standard fonts and graphic health warnings. https:// www.newscientist.com/ article/ 2122340-plain-packets-help- smokers-quit-by-killing-br and-identities/
Read more